NHS Makes Life-Extending Breast Cancer Drug Available To Patients In England

NHS Makes Life-Extending Breast Cancer Drug Available to Patients in England Patients in England living with a specific type of incurable breast cancer can now access a life-extending drug through the National Health Service NHS, two years after the treatment was initially considered too expensive for routine use. The drug is being made available following changes to its funding arrangements, allowing eligible patients with advanced breast cancer to receive the treatment through the NHS. The development is expected to provide another treatment option for people living with incurable disease, with the drug designed to help slow the progression of cancer and extend patients’ lives. The treatment had previously been assessed by the National Institute for Health and Care Excellence (NICE), which concluded that it was not cost-effective for routine NHS use under the arrangements available at the time. The subsequent agreement means eligible patients in England can now receive the drug under NHS care, potentially giving patients and their families access to additional time and treatment options. The decision comes amid continuing efforts to expand access to innovative cancer medicines while balancing the cost of treatments with the resources available to the health service.